Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue
Metabolic syndrome can be defined as a state of disturbed metabolic homeostasis characterized by visceral obesity, atherogenic dyslipidemia, arterial hypertension, and insulin resistance. The growing prevalence of metabolic syndrome will certainly contribute to the burden of cardiovascular disease....
| Autor principal: | |
|---|---|
| Outros Autores: | , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2018
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10400.23/1255 |
| País: | Portugal |
| Oai: | oai:repositorio.hospitaldebraga.pt:10400.23/1255 |